About Us
Over the last two decades, Sun Pharma has established itself as a leading player in the generics market in the U.S. We have become the eighth-largest generics pharmaceutical company in the U.S. and are ranked second by prescriptions in the U.S. dermatology market. We are rapidly ramping up our presence in the specialty branded market, with dermatology, ophthalmology, and oncology as key target segments. Today, our U.S. business makes up 30% of our global revenue and we’re continuing to invest in our people and our shared success.
How We Work
At Sun Pharma, we have found strength in our diversity, imbued by our culture of mutual respect, empathy, and adhering to the highest ethical standards. Our approach and culture are represented through Sunology: the Sun Pharma way of life.
Key Milestones
-
1998
Entered the U.S. market through the acquisition of Caraco Pharmaceutical Laboratories
-
2010
Acquired Taro Pharmaceuticals to enter dermatology market
-
2013
Acquired DUSA Pharmaceuticals, entering the branded specialty market
-
2015
Acquired Ranbaxy Laboratories, expanding generics portfolio
Vision
We’re reaching people and touching lives globally as a leading provider of valued medicines.
Our Values
Sunology, a combination of Sun and Ideology, is the way of life at Sun Pharma. We practice humility, integrity, passion, and innovation.
Jobs for You
You have no recently viewed jobs.
You have no saved jobs.
Get Job Alerts
Sign up below to receive job alerts, our monthly newsletter, and advice from our recruiters straight to your inbox.
